Clinical trials
Diabetes clinical trials
Below are recruiting diabetes clinical trials, each written for real people, not researchers. We’re tracking 2,136 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07240012Recruiting
Automated insulin delivery before and during pregnancy for type 1 diabetes
This trial tests whether an automated insulin delivery system can improve blood sugar control compared to usual insulin methods before and during pregnancy in women with type 1 diabetes.
Aalborg, AalborgAges 18–45 - NCT07248631Recruiting
Exercises and mindful walking for diabetic nerve pain
This study tests whether combining foot and ankle exercises with mindful walking can reduce pain and improve mobility in people with diabetic nerve damage in their feet.
Multan, Punjab ProvinceAges 3.3 years–6.3 years - NCT07243886Recruiting
Mobile app for high blood pressure or diabetes in pregnancy
This study tests whether a mobile app can help monitor your blood pressure or blood sugar during pregnancy if you have high blood pressure or diabetes. It aims to make it easier to manage your condition and stay connected with your healthcare team.
BiratnagarAges 18 years+ - NCT07247734RecruitingPhase 2
Colchicine for insulin sensitivity in type 1 diabetes
This trial tests whether a daily oral medication called colchicine can improve how your body responds to insulin. It is for people with type 1 diabetes who have ongoing low-level inflammation and are already using a continuous glucose monitor.
Gentofte MunicipalityAges 18–80 - NCT07241221Recruiting
Myo-inositol supplement for diabetes in pregnancy
This study tests whether taking a supplement called myo-inositol (a natural vitamin-like substance) during pregnancy can help manage blood sugar in women with type 2 diabetes. It may improve outcomes for you and your baby.
Singapore, SingaporeAges 21–45 - NCT07231419RecruitingPhase 3
Study of suzetrigine for diabetic nerve pain
This trial tests an experimental pain drug called suzetrigine for people with diabetic peripheral neuropathy (nerve damage from diabetes that causes pain in the feet and legs). It aims to see if the drug can safely reduce pain over time.
Birmingham, AlabamaAges 18–80 - NCT07235085RecruitingPhase 3
Study of OTX-TKI implant for moderate to severe NPDR
This study tests an eye implant (OTX-TKI) that slowly releases a medicine to slow or stop worsening of non-proliferative diabetic retinopathy (NPDR) — an early form of diabetic eye disease. It's for people with moderately severe to severe NPDR who haven't had significant treatments like laser or injections in that eye.
Hagerstown, MarylandAges 18 years+ - NCT06473480Recruiting
Continuous glucose sensor vs. fingerstick in hospital patients
This study compares a continuous glucose monitor (a small sensor on the skin) with the usual fingerstick method for checking blood sugar in hospitalized patients. It aims to see if the sensor is more convenient and just as accurate.
Køge, KøgeAges 18–110 - NCT07237685Recruiting
Diabetes and heart artery plaque progression study
This study uses a follow-up CT scan of your heart arteries to see how diabetes-related plaque buildup changes over time. It may help researchers understand how well current diabetes treatments are protecting your heart.
AmsterdamAges 18 years+ - NCT07231341Recruiting
Insulin resistance study in gestational diabetes
This study looks at insulin resistance in pregnant women with gestational diabetes. It aims to understand how the body uses insulin during pregnancy to help improve care for women with this condition.
AarhusAges 18 years+ - NCT07239700Enrolling by invitation
Buzzy and TickleFlex for easier insulin shots in kids
This study tests two devices, Buzzy and TickleFlex, to see if they can reduce pain and fear during insulin injections in children with type 1 diabetes. It may help make daily injections more comfortable.
Hakkari, CentreAges 6–12 - NCT07233434Recruiting
Diabetes screening with sugar drink test in Guadeloupe
This study checks if a special sugar-drink test can find type 2 diabetes in people whose fasting blood sugar is normal but whose HbA1c is slightly high. It is for adults 18–64 of African or Indian descent with certain risk factors.
Pointe-à-Pitre, GuadeloupeAges 18–65 - NCT07236879Recruiting
AI eye test for diabetes patients in primary care
This trial uses an artificial intelligence (AI) system to check for diabetic eye disease (retinopathy) during your regular doctor visit. It aims to detect problems early so you can get treatment sooner.
Porto Alegre, Rio Grande do SulAges 18 years+ - NCT06903546RecruitingPhase 4
Propolis for cholesterol in type 2 diabetes
This trial tests if taking propolis (a bee product) can help lower cholesterol in people with type 2 diabetes. It is for those whose diabetes is well-controlled and who are already on cholesterol medication.
JakartaAges 35–59 - NCT01802034Recruiting
Study kidney samples to understand autoimmune, inflammatory, and diabetic disease
This trial collects and studies kidney tissue samples to better understand what drives kidney problems linked to autoimmune, inflammation, and diabetes. Your participation may help researchers develop better ways to diagnose and treat these conditions.
New York, New YorkAges 18 years+ - NCT06618612Recruiting
Wound matrix for diabetic foot ulcers
This study tests if a special wound dressing (collagen matrix with antimicrobial) plus standard care helps diabetic foot ulcers heal better than standard care alone. It's for people with diabetes who have a foot sore that hasn't healed for at least 4 weeks.
Clevland, OhioAges 18 years+ - NCT06838416Recruiting
Study on finerenone for kidney health in type 2 diabetes
This trial tests if a medicine called finerenone can protect kidney function in people with type 2 diabetes and early-to-moderate chronic kidney disease. It may be an option if you are already on blood pressure medication and have some protein in your urine.
Suzhou, JiangsuAges 18 years+ - NCT07224893RecruitingPhase 4
Once vs Twice Daily Insulin in Pregnant Diabetes
This trial compares taking insulin glargine once a day versus twice a day for pregnant women with type 2 diabetes. It aims to find which schedule helps manage blood sugar better during pregnancy.
Norfolk, VirginiaAges 18 years+ - NCT07223268Recruiting
Support program for diabetic foot problems
This study tests a program that provides extra help and resources to people with diabetes who have a foot ulcer or a toe amputation. The goal is to see if this support helps them manage their condition and avoid future problems.
Atlanta, GeorgiaAges 18 years+ - NCT07225218Recruiting
Diabetes prevention program for UCLA students
This study tests a wellness program for UCLA undergraduates who are at risk for developing diabetes. It aims to help students prevent diabetes through support and education.
Los Angeles, CaliforniaAges 17–25 - NCT07223333RecruitingPhase 1
Safety study of an investigational drug in healthy volunteers and people with type 2 diabetes
This early-phase study tests a new investigational drug called PATAS, first in healthy volunteers and then in people with type 2 diabetes, to see how safe it is and how the body handles it. It may help future treatments for diabetes, but it does not prove effectiveness yet.
Chandler, ArizonaAges 18–65 - NCT07222137RecruitingPhase 3
Baricitinib to delay type 1 diabetes in at-risk people
This trial tests if baricitinib, a pill that calms the immune system, can slow down or delay the onset of type 1 diabetes in children and adults who are at high risk. It is for people whose blood sugar is already starting to rise but who do not yet need insulin.
Santa Barbara, CaliforniaAges 1–35 - NCT07222332RecruitingPhase 3
Baricitinib for new type 1 diabetes to save insulin-making cells
This trial tests if baricitinib, a pill that calms the immune system, can protect the remaining insulin-making cells in people newly diagnosed with type 1 diabetes. If it works, you might keep making some of your own insulin longer.
Aurora, ColoradoAges 1–35 - NCT07227805Recruiting
Study of a new automated insulin system for diabetes
This study tests a new experimental automated insulin delivery system for people with type 1 or type 2 diabetes who already use a specific insulin pump (MiniMed 780G with Simplera Sync sensor). The goal is to see if the new system is safe and works well to help manage blood sugar.
AntwerpAges 2 years+
Hear when a new Diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for diabetes?
- Yes. Clin2 currently lists 2,136 recruiting diabetes studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a diabetes trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a diabetes trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.